Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Recruiting now

Conditions studied: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8

In brief

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Key facts

Study ID

NCT06595160

Run by

Emory University

People needed

87

Starts

2024-08-05

Expected to finish

2027-08-07

Last updated by the study team

2025-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• * Age ≥ 18 years with signed informed consent form
• Patients must have a histological diagnosis of PDAC
• Resectable or borderline resectable PDAC on imaging

You may not qualify if…

• * Patients with locally advanced and metastatic stage IV PDAC
• Patients who have already received or completed neoadjuvant chemotherapy for PDAC
• Patients with active malignancy receiving systemic therapy

Where it is running

• Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.